Xiamen Amoytop Biotech Co., Ltd.

This early-stage study tested the safety and how the body handles multiple doses of telpegfilgrastim in 18 non-pregnant women, some of whom had a history of preeclampsia. The goal was to gather safety data and measure drug levels in the blood, not to treat or prevent the conditio…

This early-stage study tested the safety and tolerability of a new drug called ACT500 in 72 healthy Chinese adults. Participants received either a single dose or multiple doses of the drug or a placebo. The goal was not to treat any disease but to see if the drug is safe and how …